DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1

Virology

Volumn 328, Issue 2, 2004, Pages 292-300

  Bower, Joseph F ^a   Green, Thomas D ^b   Ross, Ted M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

C3d; CD4; DNA vaccine; Envelope; HIV 1; Molecular adjuvant; Neutralizing antibody

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; DNA VACCINE; EPITOPE; GLYCOPROTEIN GP 120; HYBRID PROTEIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PROTEIN SUBUNIT; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS ENVELOPE; VIRUS INFECTION;

AIDS VACCINES; ANIMALS; ANTIGENS, CD4; COMPLEMENT C3D; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; IMMUNIZATION; INJECTIONS, INTRADERMAL; MICE; MICE, INBRED BALB C; PLASMIDS; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; VACCINES, DNA;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

EID: 5344220935     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.07.031     Document Type: Article

References (46)

1. J.F. Bower, X. Yang, J. Sodroski, and T.M. Ross Elicitation of improved neutralizing antibodies using DNA vaccines expressing soluble stabilized HIV-1 envelope glycoprotein trimers conjugated to C3d J. Virol. 78 2004 4710 4719
2. A. Buchacher, R. Predl, K. Strutzenberger, W. Steinfellner, A. Trkola, and M. Purtscher Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epsteinâ€"Barr virus transformation for peripheral blood lymphocyte immortalization AIDS Res. Hum. Retroviruses 10 1994 359 369
3. K. Cole, J. Rowles, B. Jagerski, M. Murphey-Corb, T. Unangst, J. Clements, J. Robinson, M. Wyand, R. Desrosiers, and R. Montelaro Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity J. Virol. 71 1997 5069 5079
4. A. Dalgleish, P. Beverley, P. Clapham, M. Crawford, and R. Weiss The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus Nature 312 1984 763 767
5. P.W. Dempsey, M.E.D. Allison, S. Akkaraju, C.C. Goodnow, and D.T. Fearon C3d of complement as a molecular adjuvant: bridging innate and acquired immunity Science 271 1996 348 350
6. A. DeVico, A. Sliver, A. Thornton, M. Sarngadharan, and R. Pal Covalently crosslinked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolates Virology 218 1996 258 263
7. B.J. Doranz, S.S. Baik, and R.W. Doms Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events J. Virol. 73 1999 10346 10358
8. T. Fouts, R. Tuskan, K. Godfrey, M. Reitz, D. Hone, G. Lewis, and A. DeVico Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120â€"CD4 receptor complex J. Virol. 74 2000 11427 11436
9. T. Fouts, K. Godfrey, K. Bobb, D. Montefiori, C. Hanson, V. Kalyanaraman, A. DeVico, and R. Ral Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques Proc. Natl. Acad. Sci. U.S.A. 99 2003 11842 11847
10. Graham, B.S., 2001. NIH Vaccine Research Center Clinical Studies. http://www.vrc.nih.gov/VRC/clinstudies.htm.
11. B. Graham Clinical trials of HIV vaccines Annu. Rev. Med. 53 2002 207 221
12. T.D. Green, B.R. Newton, P.A. Rota, Y. Xu, H.L. Robinson, and T.M. Ross C3d enhancement of neutralizing antibodies to measles hemagglutinin Vaccine 20 1â€"2 2001 242 248
13. T.D. Green, D.C. Montefiori, and T.M. Ross Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d J. Virol. 77 3 2003 2046 2055
14. K.M. Haas, F.R. Toapanta, J.A. Oliver, J.C. Poe, J. Weis, D.R. Karp, J.F. Bower, T.M. Ross, and T.F. Tedder C3d functions as a molecular adjuvant in the absence of CD21/35 expression J. Immunol. 172 2004 5833 5837
15. J.R. Haynes, D.H. Fuller, M.D. Eisenbraun, M.J. Ford, and T.M. Pertmer A cell particle-mediated DNA immunization elicits humoral, cytotoxic, and protective immune responses AIDS Res. Hum. Retroviruses 10 1994 S43 S45
16. Y. He, P. D'Agostino, and A. Pinter Analysis of the immunogenicity properties of a single-chain polypeptide analogue of the HIV-1 gp120-CD4 complex in transgenic mice that produce human immunoglobulins Vaccine 21 2003 4421 4429
17. D. Klatzmann, E. Champagne, S. Chamaret, J. Gruest, T. Hercend, J. Gluckman, and L. Montagnier T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV Nature 312 1984 767 768
18. C. Lapham, J. Ouyang, B. Chandrasekhar, Y. Nguyen, D. Dimitrov, and H. Golding Evidence for cell-surface association between fusin and the CD4â€"gp120 complex in human cell lines Science 274 1996 602 605
19. N.L. Letvin Strategies for an HIV vaccine J. Clin. Invest. 110 2002 15 20
20. M.A. Liu, T.M. Fu, J.J. Donnelly, M.J. Caulfield, and J.B. Ulmer DNA vaccines. Mechanisms for generation of immune responses Adv. Exp. Med. Biol. 42 1998 187 191
21. S. Lu, J. Santoro, D. Fuller, J. Haynes, and H. Robinson Use of DNAs expressing HIV-1 env and noninfectious HIV-1 particles to raise antibody responses in mice Virology 209 1995 147 154
22. S. Lu, J. Arthos, D.C. Montefiori, Yasutomi, K. Manson, and F. Mustafa Simian immunodeficiency virus DNA vaccine trial in macaques J. Virol. 70 1996 3978 3991
23. P. Maddon, D. Littman, M. Godfrey, D. Maddon, L. Chess, and R. Axel The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family Cell 42 1985 93 104
24. J.R. Mascola Defining the protective antibody response for HIV-1 Curr. Mol. Med. 3 2003 209 216
25. J.A. Mitchell, T.D. Green, R.A. Bright, and T.M. Ross Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins Vaccine 21 9â€"10 2003 902 914
26. D. Montefiori, W. Robinson, S. Schuffman, and W. Mitchell Evaluation of antiviral drugs and neutralizing antibodies to HIV by a rapid and sensitive microtiter infection assay J. Clin. Microbiol. 26 1998 231 237
27. T.M. Pertmer, M.D. Eisenbraun, D. McCabe, S.K. Prayaga, D.H. Fuller, and J.R. Haynes Gene gun based nucleic acid immunization eliciting of humoral and cytotoxic T lymphocyte response following epidermal delivery of nanogram quantitation of DNA Vaccine 13 1995 1427 1430
28. M.R. Posner Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120 J. Acquired Immune Defic. Syndr. 6 1993 7 14
29. A. Raja, M. Venturi, P. Kwong, and J. Sodroski CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5 J. Virol. 77 2003 713 718
30. H.L. Robinson, and T.M. Pertmer DNA vaccines for viral infections: basic studies and applications Adv. Virus Res. 55 2000 1 74
31. T.M. Ross, P.D. Bieniasz, and B.R. Cullen Role of chemokine receptors in HIV-1 infection and pathogenesis Adv. Virus Res. 52 1999 233 267
32. T.M. Ross, Y. Xu, R.A. Bright, and H.L. Robinson C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge Nat. Immunol. 1 2 2000 127 131
33. T.M. Ross, Y. Xu, T.D. Green, D.C. Montefiori, and H.L. Robinson Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins AIDS Res. Hum. Retroviruses 17 9 2001 829 835
34. K. Salzwedel, E. Smith, B. Dey, and E. Berger Sequential CD4-coreceptor interactions in HIV-1 Env function J. Virol. 74 2000 326 333
35. Q. Sattentau, and J. Moore Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding J. Exp. Med. 174 1991 407 415
36. Q. Sattentau, J. Moore, F. Vignaux, F. Traincard, and P. Poignard Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding J. Virol. 67 1993 7383
37. P. Spearman HIV vaccine development: lessons from the past and promise for the future Curr. HIV Res. 1 2003 101 120
38. N. Sullivan, Y. Sun, Q. Satterntau, M. Thali, D. Wu, G. Denisova, J. Gershoni, J. Robinson, and J. Sodroski CD4-induced conformational changes in the HIV-1 gp120 glycoprotein: consequences for virus entry and neutralization J. Virol. 72 1998 4694 4703
39. M. Thali Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120â€"CD4 binding Virology 67 1993 3978 3988
40. M. Thali, C. Furman, E. Helseth, H. Repke, and J. Sodroski Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events J. Virol. 66 1992 5516 5524
41. F.R. Toapanta, and T.M. Ross Mouse strain-dependent differences in enhancement of immune responses by C3d Vaccine 22 2004 1773 1781
42. A. Trkola, T. Dragic, J. Arthos, J. Binley, W. Olson, G. Allaway, C. Cheng-Meyer, J. Robinson, and J. Moore CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 Nature 384 1996 184 187
43. D. Weissman, R. Rabin, J. Arthos, A. Rubbert, M. Dybul, R. Swofford, S. Venkatesan, J. Farber, and A. Fauci Macrophage-tropic HIV and SIV envelope proteins induce a signal through the chemokine receptor Nature 389 1997 981 985
44. L. Wu, N. Gerard, R. Wyatt, H. Choe, C.N.R. Parolin, A. Borsetti, A. Cardoso, E.W.N. Desjardin, C. Gerard, and J. Sodroski CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 Nature 384 1996 179 183
45. R. Wyatt, and J. Sodroski The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens Science 280 1998 1884 1888
46. S. Xiang, P. Kwong, R. Gupata, C. Rizzuto, D. Caspoer, R. Wyatt, L. Wang, W. Hendrickson, M. Doyle, and J. Sodroski Mutagenic stabilization and/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein J. Virol. 76 2002 9888 9899